BNP Paribas Exane analyst Peter Verdult initiates coverage on AstraZeneca (AZN:LN) (NASDAQ: AZN) with a Outperform rating and a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE